Records flagged by AX-R12
The main peak trails far enough that its trailing boundary is drawn by judgement rather than by geometry. Predicate: asymmetry > 1.50. Why this rule exists and what it is not →
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041429 | Retatrutide | QYB | QYB-2604-B4920 | Medutest | 2026-Q3 | 98.53 | 2.69 | 99.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041529 | Retatrutide | QSC | QSC-2511-M6429 | Janoshik | 2026-Q1 | 99.43 | 0.94 | 98.1 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018624 | Retatrutide | QSC | QSC-2502-D5359 | Kestrel | 2025-Q3 | 99.03 | 7.06 | 104.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020665 | Tirzepatide | SGN | SGN-2506-J8349 | PeptideMeter | 2025-Q3 | 97.65 | 1.99 | 99.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-005307 | Tirzepatide | BCH | BCH-2404-N5218 | PeptideMeter | 2024-Q3 | 98.10 | 3.32 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004443 | Semaglutide | GSP | GSP-2405-W3331 | Medutest | 2024-Q2 | 99.10 | 2.90 | 101.4 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004455 | BPC-157 | GSP | GSP-2402-G3728 | VendorInvestigate | 2024-Q1 | 98.93 | 3.69 | 90.4 | Buyer-sourced | 1 | MARGINAL |